Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122575754 | 12257575 | 4 | F | 2007 | 20160718 | 20160412 | 20160727 | EXP | US-TEVA-650131USA | TEVA | 45.64 | YR | F | Y | 0.00000 | 20160727 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122575754 | 12257575 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 2400 MILLIGRAM DAILY; | N | 76017 | 800 | MG | TID | ||||||
| 122575754 | 12257575 | 2 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 3200 MILLIGRAM DAILY; | N | 76017 | 800 | MG | QID | ||||||
| 122575754 | 12257575 | 3 | SS | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 1600 MILLIGRAM DAILY; | N | 76017 | 800 | MG | BID | ||||||
| 122575754 | 12257575 | 4 | SS | LYRICA | PREGABALIN | 1 | Unknown | 675 MILLIGRAM DAILY; | M57238 | 0 | 225 | MG | CAPSULE | TID | |||||
| 122575754 | 12257575 | 5 | SS | LYRICA | PREGABALIN | 1 | M57238 | 0 | |||||||||||
| 122575754 | 12257575 | 6 | SS | LYRICA | PREGABALIN | 1 | M57238 | 0 | |||||||||||
| 122575754 | 12257575 | 7 | C | WELLBUTRIN | BUPROPION HYDROCHLORIDE | 1 | 300 MILLIGRAM DAILY; | 0 | 150 | MG | BID | ||||||||
| 122575754 | 12257575 | 8 | C | TRAMADOL. | TRAMADOL | 1 | 150 MILLIGRAM DAILY; | 0 | 50 | MG | TID | ||||||||
| 122575754 | 12257575 | 9 | C | TRAMADOL. | TRAMADOL | 1 | 0 | ||||||||||||
| 122575754 | 12257575 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | ||||||||
| 122575754 | 12257575 | 11 | C | REMERON | MIRTAZAPINE | 1 | 30 MILLIGRAM DAILY; | 0 | 30 | MG | QD | ||||||||
| 122575754 | 12257575 | 12 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | ONE PUFF AS NEEDED | 0 | |||||||||||
| 122575754 | 12257575 | 13 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 40 MILLIGRAM DAILY; | 0 | 40 | MG | QD | ||||||||
| 122575754 | 12257575 | 14 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | 75 MILLIGRAM DAILY; | 0 | 75 | MG | QD | ||||||||
| 122575754 | 12257575 | 15 | C | NORTRIPTYLINE | NORTRIPTYLINE | 1 | 10 MILLIGRAM DAILY; | 0 | 10 | MG | QD | ||||||||
| 122575754 | 12257575 | 16 | C | METOPROLOL. | METOPROLOL | 1 | 25 MILLIGRAM DAILY; | 0 | 25 | MG | QD | ||||||||
| 122575754 | 12257575 | 17 | C | MELOXICAM. | MELOXICAM | 1 | 15 MILLIGRAM DAILY; | 0 | 15 | MG | QD | ||||||||
| 122575754 | 12257575 | 18 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | 120 MILLIGRAM DAILY; | 0 | 60 | MG | BID | ||||||||
| 122575754 | 12257575 | 19 | C | LISINOPRIL. | LISINOPRIL | 1 | 10 MILLIGRAM DAILY; | 0 | 10 | MG | QD | ||||||||
| 122575754 | 12257575 | 20 | C | LASIX | FUROSEMIDE | 1 | EVERY OTHER DAY | 0 | 20 | MG | |||||||||
| 122575754 | 12257575 | 21 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122575754 | 12257575 | 1 | Pain |
| 122575754 | 12257575 | 2 | Neuropathy peripheral |
| 122575754 | 12257575 | 4 | Neuropathy peripheral |
| 122575754 | 12257575 | 5 | Fibromyalgia |
| 122575754 | 12257575 | 6 | Neuralgia |
| 122575754 | 12257575 | 8 | Neuropathy peripheral |
| 122575754 | 12257575 | 9 | Neuralgia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122575754 | 12257575 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122575754 | 12257575 | Drug ineffective | |
| 122575754 | 12257575 | Insomnia | |
| 122575754 | 12257575 | Intentional product misuse | |
| 122575754 | 12257575 | Neuralgia | |
| 122575754 | 12257575 | Pain | |
| 122575754 | 12257575 | Physical disability | |
| 122575754 | 12257575 | Product substitution issue | |
| 122575754 | 12257575 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122575754 | 12257575 | 4 | 2010 | 20160322 | 0 | |
| 122575754 | 12257575 | 7 | 2010 | 0 | ||
| 122575754 | 12257575 | 8 | 2010 | 0 | ||
| 122575754 | 12257575 | 10 | 2010 | 0 | ||
| 122575754 | 12257575 | 11 | 2010 | 0 | ||
| 122575754 | 12257575 | 12 | 2010 | 0 | ||
| 122575754 | 12257575 | 13 | 2010 | 0 | ||
| 122575754 | 12257575 | 14 | 2010 | 0 | ||
| 122575754 | 12257575 | 15 | 2010 | 0 | ||
| 122575754 | 12257575 | 16 | 2010 | 0 | ||
| 122575754 | 12257575 | 17 | 2010 | 0 | ||
| 122575754 | 12257575 | 18 | 2010 | 0 | ||
| 122575754 | 12257575 | 19 | 2010 | 0 | ||
| 122575754 | 12257575 | 20 | 2010 | 0 | ||
| 122575754 | 12257575 | 21 | 2010 | 0 |